QbD: Quality Assurance For Drug R&D Under New Regulations
In view of the imperative application of QbD in China’s drug R&D, Dr. Wang Xingwang told R&D supervisors with a number of specific R&D examples: some QbD elements can be appropriately added at different stages of R&D, such as R&D objectives (QTPP), CQA, CMA, CPP and control strategies; QbD tools, such as risk assessment and […]
QbD: Quality Assurance For Drug R&D Under New Regulations Read More »